Vanda Pharmaceuticals | VNDA - Ebit

Stock Price
7.44
Daily Change
0.02 0.27%
Monthly
0.40%
Yearly
56.63%
Q1 Forecast
4.24

Vanda Pharmaceuticals reported $-10.28M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Agios Pharmaceuticals USD -116.87M 10.19M Sep/2025
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alnylam Pharmaceuticals USD -29.96M 34.85M Sep/2025
Anika Therapeutics USD -4.28M 3.58M Mar/2025
Arrowhead Research USD 40.81M 17.01M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Enanta Pharmaceuticals USD -23.54M 6.31M Dec/2024
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
Halozyme Therapeutics USD 217.92M 15.48M Sep/2025
Heron Therapeutics USD -4.46M 5.76M Sep/2024
Insmed USD -261.35M 7.48M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Lexicon Pharmaceuticals USD -49.63M 5.39M Sep/2023
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
Moderna USD -260M 557M Sep/2025
Novartis USD 4.48B 343M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Puma Biotechnology USD -2.2M 11.41M Jun/2024
Sanofi EUR 1.7B 2.17B Dec/2025
Takeda JPY 257.49B 568.56B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Ultragenyx Pharmaceutical USD -170.89M 22.68M Sep/2025
Vanda Pharmaceuticals USD -10.28M 721K Dec/2024
Veracyte USD 23.11M 8.8M Sep/2025